InvestorsHub Logo
Followers 0
Posts 17
Boards Moderated 0
Alias Born 02/12/2017

Re: None

Tuesday, 08/14/2018 2:29:45 PM

Tuesday, August 14, 2018 2:29:45 PM

Post# of 42
I rarely buy at IPO but I find that the significant backers and the positive clinical trials will make LQDA a good candidate for anyone interested in new pharma (neopharmacy?). As the article below also stipulates, the dilution is low and brings the attraction of this one up. I'm in to see what 2019 will bring.

https://seekingalpha.com/article/4196391-liquidia-ipo-phase-3-clinical-stage-interested-bill-gates-foundation
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent LQDA News